Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Industry News

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

July 01, 2019

News Industry News

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

March 14, 2019

News Industry News

4C Medical Exceeds $8 Million Convertible Note Financing Round Led by Anges Québec

July 20, 2017

News Industry News

4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum

June 08, 2017

News Industry News

LivaNova Acquires Caisson Interventional, LLC

May 02, 2017

News Industry News

Valcare Medical, an Accelmed Portfolio Company, Announces Successful First-In-Human Procedures of the Amend™ Catheter Delivered Annuloplasty Ring

June 20, 2016

News Industry News

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

March 07, 2016

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) Reports First Patient Treated for Mitral Regurgitation (“MR”)

November 22, 2015

News Industry News

MValve Technologies Implants First Human Catheter Based Mitral Valve Replacement System

October 05, 2015

News Industry News

Edwards Lifesciences Corporation Completes Acquisition Of CardiAQ

August 27, 2015

News Industry News

Medtronic to Acquire Twelve, Inc., Developer of Transcatheter Mitral Valve Replacement Device

August 25, 2015

News Industry News

Edwards Lifesciences Enters Into Agreement To Acquire CardiAQ

July 10, 2015

News Industry News

CardiAQ™ Valve Technologies reports first-in-human percutaneous transfemoral, transseptal implantation with its second generation transcatheter bioprosthetic mitral heart valve

June 23, 2015

News Industry News

Edwards Pauses Enrollment In Early Stage Mitral Program

May 19, 2015

Advertisement

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

4C Medical Exceeds $8 Million Convertible Note Financing Round Led by Anges Québec

4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum

LivaNova Acquires Caisson Interventional, LLC

Valcare Medical, an Accelmed Portfolio Company, Announces Successful First-In-Human Procedures of the Amend™ Catheter Delivered Annuloplasty Ring

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

NaviGate Cardiac Structures Inc. (“NCSI”) Reports First Patient Treated for Mitral Regurgitation (“MR”)

MValve Technologies Implants First Human Catheter Based Mitral Valve Replacement System

Edwards Lifesciences Corporation Completes Acquisition Of CardiAQ

Medtronic to Acquire Twelve, Inc., Developer of Transcatheter Mitral Valve Replacement Device

Edwards Lifesciences Enters Into Agreement To Acquire CardiAQ

CardiAQ™ Valve Technologies reports first-in-human percutaneous transfemoral, transseptal implantation with its second generation transcatheter bioprosthetic mitral heart valve

Edwards Pauses Enrollment In Early Stage Mitral Program

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content